GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 794 filers reported holding GLAXOSMITHKLINE PLC in Q4 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $76,538,000 | -4.4% | 2,033,412 | +3.6% | 3.46% | +29.1% |
| Q2 2020 | $80,031,000 | +5.4% | 1,962,014 | -2.1% | 2.68% | -12.2% |
| Q1 2020 | $75,897,000 | -19.4% | 2,003,100 | +0.0% | 3.05% | +30.2% |
| Q4 2019 | $94,120,000 | +9.6% | 2,002,973 | -0.4% | 2.34% | +12.7% |
| Q3 2019 | $85,839,000 | +7.1% | 2,011,218 | +0.4% | 2.08% | +15.3% |
| Q2 2019 | $80,132,000 | +0.1% | 2,002,291 | +4.5% | 1.80% | +3.6% |
| Q1 2019 | $80,057,000 | +185.2% | 1,915,709 | +1.7% | 1.74% | +162.0% |
| Q4 2018 | $28,074,000 | -64.6% | 1,882,869 | -5.9% | 0.66% | -57.8% |
| Q3 2018 | $79,381,000 | -8.4% | 2,000,017 | -7.0% | 1.57% | +0.8% |
| Q2 2018 | $86,666,000 | -19.1% | 2,149,989 | -21.6% | 1.56% | -9.9% |
| Q1 2018 | $107,186,000 | +14.3% | 2,743,443 | +3.8% | 1.73% | +42.4% |
| Q4 2017 | $93,745,000 | -15.4% | 2,642,926 | -3.1% | 1.22% | -10.2% |
| Q3 2017 | $110,775,000 | +3.0% | 2,728,458 | +9.4% | 1.36% | -8.9% |
| Q2 2017 | $107,574,000 | -3.1% | 2,494,769 | -2.9% | 1.49% | +1.7% |
| Q1 2017 | $111,063,000 | +12.3% | 2,568,415 | +0.0% | 1.46% | +8.9% |
| Q4 2016 | $98,894,000 | -13.7% | 2,568,013 | -3.4% | 1.34% | -19.3% |
| Q3 2016 | $114,646,000 | +27.5% | 2,658,155 | +28.1% | 1.66% | +7.8% |
| Q2 2016 | $89,939,000 | -99.6% | 2,075,187 | +316.6% | 1.54% | +390.2% |
| Q1 2016 | $20,198,563,000 | +106449.4% | 498,115 | +6.0% | 0.32% | +7.5% |
| Q4 2015 | $18,957,000 | -9.5% | 469,830 | -13.8% | 0.29% | -9.3% |
| Q3 2015 | $20,949,000 | -1.5% | 544,855 | +6.7% | 0.32% | +9.9% |
| Q2 2015 | $21,262,000 | +1.0% | 510,500 | +11.9% | 0.29% | +11.8% |
| Q1 2015 | $21,061,000 | +140.8% | 456,380 | +123.0% | 0.26% | +150.5% |
| Q4 2014 | $8,745,000 | -8.6% | 204,625 | -1.7% | 0.10% | 0.0% |
| Q3 2014 | $9,568,000 | +20.2% | 208,125 | +39.8% | 0.10% | +31.2% |
| Q2 2014 | $7,960,000 | +0.1% | 148,850 | +0.0% | 0.08% | +15.9% |
| Q1 2014 | $7,950,000 | -28.9% | 148,800 | -28.9% | 0.07% | -29.6% |
| Q4 2013 | $11,176,000 | +5.2% | 209,325 | -1.2% | 0.10% | -3.0% |
| Q3 2013 | $10,626,000 | +0.4% | 211,800 | 0.0% | 0.10% | +9.8% |
| Q2 2013 | $10,584,000 | – | 211,800 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |